A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir-Ivermectin-Niclosamide in mild-to-moderate COVID-19 adult patients

Authors
Category Primary study
Registry of TrialsTCTR
Year 2023
This article has no abstract
Epistemonikos ID: 0a819a89a3094e59e8dc097b0e1a7fcfaa62e7b4
First added on: Oct 02, 2023